PMC:7558914 / 767-978 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":133,"end":141},"obj":"Species"},{"id":"44","span":{"begin":12,"end":30},"obj":"Chemical"},{"id":"45","span":{"begin":36,"end":48},"obj":"Chemical"},{"id":"46","span":{"begin":52,"end":71},"obj":"Chemical"},{"id":"67","span":{"begin":165,"end":175},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D006886"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D017963"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C558899"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"). Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combination"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":165,"end":175},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"). Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combination"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":3,"end":102},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"). Combined hydroxychloroquine with azithromycin or lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combination"}